Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies

Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer

(2015) Talha Shaikh et al.   ANNALS OF THORACIC SURGERY

Prognostic significance of a positive radial margin after esophageal cancer resection

(2015) Sebastien Gilbert et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer

(2014) Joel Shapiro et al.   ANNALS OF SURGERY

Does Timing of Surgical Procedure After Neoadjuvant Chemoradiation Affect Outcomes in Esophageal Cancer?

(2014) Williams Tessier et al.   ANNALS OF THORACIC SURGERY

Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma: Does Delayed Surgery Impact Outcome?

(2013) Chien-Hong Chiu et al.   ANNALS OF SURGICAL ONCOLOGY

Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery

(2012) Ali Aminian et al.   Journal of Cancer Research and Therapeutics

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?

(2011) Jae Y. Kim et al.   ANNALS OF THORACIC SURGERY

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Outcomes After Trimodality Therapy for Esophageal Cancer

(2010) Matthew Koshy et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus

(2010) Alberto Ruol et al.   ANNALS OF SURGERY

An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer

(2008) Hagit Tulchinsky et al.   ANNALS OF SURGICAL ONCOLOGY

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY